Apolipoprotein C-II and lipoprotein lipase activity.
D000273:Adipose Tissue / Q000201:enzymology; D000818:Animals; D053304:Apolipoprotein C-II; D001053:Apolipoproteins / Q000378:metabolism* / Q000494:pharmacology; D001056:Apolipoproteins C; D002914:Chylomicrons / Q000378:metabolism; D004727:Endothelium / Q000201:enzymology; D004789:Enzyme Activation / Q000187:drug effects; D006493:Heparin / Q000378:metabolism; D006801:Humans; D008049:Lipase / Q000378:metabolism; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009132:Muscles / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D010446:Peptide Fragments / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D014280:Triglycerides / Q000378:metabolism
D053304:Apolipoprotein C-II; D001053:Apolipoproteins; D001056:Apolipoproteins C; D002914:Chylomicrons; D008075:Lipoproteins, HDL; D008079:Lipoproteins, VLDL; D010446:Peptide Fragments; D010743:Phospholipids; D014280:Triglycerides; D006493:Heparin; D008049:Lipase; D008071:Lipoprotein Lipase